west china medical publishers

<div id="8sgz1"><ol id="8sgz1"></ol></div>

<em id="8sgz1"><label id="8sgz1"></label></em>

<em id="8sgz1"><label id="8sgz1"></label></em>

<em id="8sgz1"></em>

<div id="8sgz1"><ol id="8sgz1"><mark id="8sgz1"></mark></ol></div>

<button id="8sgz1"></button>

west china medical publishers

Article Figure Table

Relevance Release date Cited by PDF Downloads

find Keyword "心室停搏" 1 results

替格瑞洛致緩慢性心律失常或心室停搏的研究進展

West China Medical Journal 2017, 32(10): 1602-1605

替格瑞洛為一種新型的口服抗血小板 P2Y12腺苷二磷酸受體拮抗劑，該藥起效快速、藥效持續作用時間長。隨著臨床應用和研究的增加，其不良反應緩慢性心律失常或者心室停搏逐漸顯現出來。該文歸納整理有關替格瑞洛在急性冠狀動脈綜合征所致的心律失常或心室停搏文獻和臨床研究，對其引起的可能機制進行綜述。

Release date：2017-10-27 11:09 Export PDF Favorites Scan

<div id="8sgz1"><ol id="8sgz1"></ol></div>

<em id="8sgz1"><label id="8sgz1"></label></em>

<em id="8sgz1"><label id="8sgz1"></label></em>

<em id="8sgz1"></em>

<div id="8sgz1"><ol id="8sgz1"><mark id="8sgz1"></mark></ol></div>

<button id="8sgz1"></button>

欧美人与性动交α欧美精品